BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35504701)

  • 1. Assessing Breast Cancer Risks to Improve Care for an Increased-Risk Population within Eastern North Carolina.
    Shelton CH; Bowen C; Guenther WC; Jordan B; Boehmer LM; Weldon CB; Trosman JR; Ruiz A
    N C Med J; 2022; 83(3):221-228. PubMed ID: 35504701
    [No Abstract]   [Full Text] [Related]  

  • 2. The North Carolina Breast Cancer Screening Program: foundations and design of a model for reaching older, minority, rural women.
    Earp JA; Altpeter M; Mayne L; Viadro CI; O'Malley MS
    Breast Cancer Res Treat; 1995 Jul; 35(1):7-22. PubMed ID: 7612907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating a Community-Based Breast Cancer Prevention Program for Rural Underserved Latina and Black Women.
    Richman AR; Torres E; Wu Q; Kampschroeder AP
    J Community Health; 2020 Dec; 45(6):1205-1210. PubMed ID: 32529466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Women at Risk for Hereditary Breast and Ovarian Cancer Syndrome Utilizing Breast Care Nurse Navigation at Mammography and Imaging Centers.
    Appel SJ; Cleiment RJ
    J Natl Black Nurses Assoc; 2015 Dec; 26(2):17-26. PubMed ID: 27045154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating lifetime risk for breast cancer as a screening tool for identifying those who would benefit from additional services among women utilizing mobile mammography.
    Wetmore JB; Otarola L; Paulino LJ; Henry BR; Levine AF; Kone D; Ulloa J; Jandorf L; Margolies L; Vang S
    J Cancer Policy; 2022 Dec; 34():100354. PubMed ID: 35995395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population health assessment of screening mammography on breast cancer mortality in North Carolina.
    Burch AE; Irish WD; Wong JH
    Breast Cancer Res Treat; 2022 Dec; 196(3):647-656. PubMed ID: 36287307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Save our Sisters Project. A social network strategy for reaching rural black women.
    Eng E
    Cancer; 1993 Aug; 72(3 Suppl):1071-7. PubMed ID: 8334660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of Estimated Lifetime Breast Cancer Risk Among Women Undergoing Screening Mammography.
    Niell BL; Augusto B; McIntyre M; Conley CC; Gerke T; Roetzheim R; Garcia J; Vadaparampil ST
    AJR Am J Roentgenol; 2021 Jul; 217(1):48-55. PubMed ID: 33978450
    [No Abstract]   [Full Text] [Related]  

  • 11. An Evaluation of a Rural Community-Based Breast Education and Navigation Program: Highlights and Lessons Learned.
    Torres E; Richman AR; Schreier AM; Vohra N; Verbanac K
    J Cancer Educ; 2019 Apr; 34(2):277-284. PubMed ID: 29150748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between intervention exposures, changes in attitudes, and mammography use in the North Carolina Breast Cancer Screening Program.
    Rauscher GH; Earp JA; O'Malley M
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):741-7. PubMed ID: 15159304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of mammographic surveillance services in women aged 40-49 years with a moderate family history of breast cancer: a single-arm cohort study.
    Duffy SW; Mackay J; Thomas S; Anderson E; Chen TH; Ellis I; Evans G; Fielder H; Fox R; Gui G; Macmillan D; Moss S; Rogers C; Sibbering M; Wallis M; Warren R; Watson E; Whynes D; Allgood P; Caunt J
    Health Technol Assess; 2013 Mar; 17(11):vii-xiv, 1-95. PubMed ID: 23489892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing mammography utilization: a controlled study.
    Fletcher SW; Harris RP; Gonzalez JJ; Degnan D; Lannin DR; Strecher VJ; Pilgrim C; Quade D; Earp JA; Clark RL
    J Natl Cancer Inst; 1993 Jan; 85(2):112-20. PubMed ID: 8418300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the breast cancer risk distribution for women undergoing screening in British Columbia.
    Weisstock CR; Rajapakshe R; Bitgood C; McAvoy S; Gordon PB; Coldman AJ; Parker BA; Wilson C
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1084-92. PubMed ID: 23963801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
    Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
    Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Interactive Tool for Breast and Ovarian Cancer Risk Assessment (Bright Pink Assess Your Risk): Development and Usability Study.
    Hibler EA; Fought AJ; Kershaw KN; Molsberry R; Nowakowski V; Lindner D
    J Med Internet Res; 2022 Feb; 24(2):e29124. PubMed ID: 35200148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.
    Schousboe JT; Kerlikowske K; Loh A; Cummings SR
    Ann Intern Med; 2011 Jul; 155(1):10-20. PubMed ID: 21727289
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.